SUPN
Supernus Pharmaceuticals, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$43.53
−1.00%Forward multiples
Based on analyst estimates
- P/E forward
- 15.06x
- P/E 2026E
- 17.13x
- P/E 2027E
- 9.85x
- P/E 2028E
- 8.14x
- P/S forward
- 2.64x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.45x
- Price / sales
- 3.05x
- Price / cash flow
- 127.08x
Enterprise value
- Enterprise value
- $2.2B
- EV / sales
- 2.65x
- EV / EBITDA
- -138.54x
- EV / EBIT
- -19.66x
- Market cap
- $2.5B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026